Stock 002873 GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Guiyang Xintian Pharmaceutical Co.,Ltd.

Equities

002873

CNE100002QB5

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
8.47 CNY +0.24% Intraday chart for Guiyang Xintian Pharmaceutical Co.,Ltd. -0.70% -32.02%
Jun. 03 Xintian Pharmaceutical Gets Nod to Trial Chronic Non-Bacterial Prostatitis Drug; Shares Down 3% MT
May. 03 Guiyang Xintian Pharmaceutical Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has expired with 8,806,030 shares, representing 3.81% for CNY 75.3 million. CI

Business Summary

Guiyang Xintian Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, production and sales of Chinese patent drugs. The Company manufactures its products in the forms of capsules, mixture, granules, syrup, gel and tablets. The Company’s main products include Ningmitai Capsule, Kuntai Capsule, Kushen Gel and Xiaokucao Oral Liquid .The Company distributes its products in the domestic market.

Number of employees: 1,958

Sales per Business

CNY in Million2022Weight2023Weight Delta
Gynecology
70.8 %
769 70.7 % 676 70.8 % -12.08%
Urinary System
20.1 %
222 20.4 % 191 20.1 % -13.78%
Heat-clearing and Detoxification
8.5 %
80 7.4 % 81 8.5 % +1.11%
Other
0.6 %
16 1.5 % 6 0.6 % -64.16%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
1,088 100.0 % 954 100.0 % -12.29%

Managers

Managers TitleAgeSince
Da Lun Dong CEO
 Chief Executive Officer 60 95-08-10
Zhi Hui Zeng DFI
 Director of Finance/CFO 51 18-01-31
Zhong Lei He BRD
 Director/Board Member 47 21-03-31
Guang Ping Wang BRD
 Director/Board Member 54 20-08-25
Jin Hua Wang BRD
 Director/Board Member 57 95-08-10
Wei Wang IRC
 Investor Relations Contact - -
Jue Rong Chen PRN
 Corporate Officer/Principal 55 06-03-31

Members of the board

Members of the board TitleAgeSince
Da Lun Dong CEO
 Chief Executive Officer 60 95-08-10
Jin Hua Wang BRD
 Director/Board Member 57 95-08-10
Jue Rong Chen PRN
 Corporate Officer/Principal 55 06-03-31
Jie Zhang BRD
 Director/Board Member 50 21-09-14
Weijia Ji BRD
 Director/Board Member 46 19-04-18
Wan Xue An CHM
 Chairman 49 19-11-11
Ruzhen Jin BRD
 Director/Board Member 54 19-11-11
Feng Guan BRD
 Director/Board Member 42 21-09-14
Zhong Lei He BRD
 Director/Board Member 47 21-03-31
Li Jin Gao BRD
 Director/Board Member 53 23-08-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 244,547,795 132,114,423 ( 54.02 %) 15,138,117 ( 6.190 %) 54.02 %

Shareholders

NameEquities%Valuation
Rongtong Fund Management Co., Ltd.
5.116 %
11,330,000 5.116 % 13 M ¥
ICBC Credit Suisse Asset Management Co., Ltd.
0.8507 %
1,883,800 0.8507 % 2 M ¥
Everbright PGIM Fund Management Co. Ltd.
0.4461 %
987,866 0.4461 % 1 M ¥
Gfund Management Co., Ltd.
0.3090 %
684,300 0.3090 % 781 676 ¥
Fullgoal Fund Management Co., Ltd.
0.2149 %
475,800 0.2149 % 543 506 ¥
China Fund Management Co., Ltd.
0.2007 %
444,445 0.2007 % 507 690 ¥
HFT Investment Management Co., Ltd.
0.0337 %
74,700 0.0337 % 85 330 ¥
Dongxing Asset Management Co. Ltd.
0.0318 %
70,316 0.0318 % 80 322 ¥
Bosera Asset Management Co., Ltd.
0.0231 %
51,200 0.0231 % 58 486 ¥
Everbright Securities Asset Management Co., Ltd.
0.0207 %
45,800 0.0207 % 52 317 ¥

Company contact information

Guiyang Xintian Pharmaceutical Co., Ltd.

3 Gaoxin North Road Wudang District

550000, Guiyang

+

http://www.gyxtyy.com
address Guiyang Xintian Pharmaceutical Co.,Ltd.(002873)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Specialty & Advanced Pharmaceuticals

Sales per Business

Ratings for Guiyang Xintian Pharmaceutical Co.,Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
8.47
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Specialty & Advanced Pharmaceuticals

1st Jan change Capi.
GUIYANG XINTIAN PHARMACEUTICAL CO.,LTD. Stock Guiyang Xintian Pharmaceutical Co.,Ltd.
-32.02% 253M
MERCK KGAA Stock Merck KGaA
+7.04% 73.13B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+31.10% 10.38B
YUHAN CORPORATION Stock Yuhan Corporation
+37.94% 5.16B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-17.33% 4.73B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+21.49% 3.81B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
+24.92% 2.26B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-36.84% 1.88B
CHANGCHUN BCHT BIOTECHNOLOGY CO. Stock Changchun BCHT Biotechnology Co.
-43.31% 1.77B
VELOXIS PHARMACEUTICALS A/S Stock Veloxis Pharmaceuticals A/S
-0.50% 1.64B
Specialty & Advanced Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 002873 Stock
  4. Company Guiyang Xintian Pharmaceutical Co.,Ltd.